This site is intended for Healthcare Professionals only

Incorrect username and/or password, please try again or click to reset.

Hydroxyethyl starch (HES) products - increased risk of renal dysfunction and mortality

2014-12-17 15:00:57 (11 year(s) ago)

Summary

(B Braun Melsungen AG and Fresenius Kabi Limited) Increased risk of renal dysfunction and mortality in critically ill or septic patients– class 1 action within 48 hours. (EL (13)A/18)

Read full MHRA article

Respond to this alert

Sign up for your FREE ticket to see PharmData at the Pharmacy Show to see our latest products and features demonstrated live!